Literature DB >> 15590651

Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization.

Smitha V Bava1, Vineshkumar T Puliyappadamba, Ayswaria Deepti, Asha Nair, Devarajan Karunagaran, Ruby John Anto.   

Abstract

Taxol is the best anticancer agent that has ever been isolated from plants, but its major disadvantage is its dose-limiting toxicity. In this study, we report with mechanism-based evidence that curcumin, a nontoxic food additive commonly used by the Indian population, sensitizes tumor cells more efficiently to the therapeutic effect of Taxol. A combination of 5 nm Taxol with 5 microm curcumin augments anticancer effects more efficiently than Taxol alone as evidenced by increased cytotoxicity and reduced DNA synthesis in HeLa cells. Furthermore, our results reveal that this combination at the cellular level augments activation of caspases and cytochrome c release. This synergistic effect was not observed in normal cervical cells, 293 cells (in which Taxol down-regulates nuclear factor-kappaB (NF-kappaB)), or HeLa cells transfected with inhibitor kappaBalpha double mutant (IkappaBalpha DM), although the transfection itself sensitized the cells to Taxol-induced cytotoxicity. Evaluation of signaling pathways common to Taxol and curcumin reveals that this synergism was in part related to down-regulation of NF-kappaB and serine/threonine kinase Akt pathways by curcumin. An electrophoretic mobility shift assay revealed that activation of NF-kappaB induced by Taxol is down-regulated by curcumin. We also noted that curcumin-down-regulated Taxol induced phosphorylation of the serine/threonine kinase Akt, a survival signal which in many instances is regulated by NF-kappaB. Interestingly, tubulin polymerization and cyclin-dependent kinase Cdc2 activation induced by Taxol was not affected by curcumin. Altogether, our observations indicate that Taxol in combination with curcumin may provide a superior therapeutic index and advantage in the clinic for the treatment of refractory tumors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15590651     DOI: 10.1074/jbc.M410647200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  Dynamic monitoring of apoptosis in chemotherapies with multiple fluorescence reporters.

Authors:  Yunlong Li; Da Xing; Qun Chen
Journal:  Mol Imaging Biol       Date:  2009-01-09       Impact factor: 3.488

Review 2.  Pancreatic cancer: pathogenesis, prevention and treatment.

Authors:  Fazlul H Sarkar; Sanjeev Banerjee; Yiwei Li
Journal:  Toxicol Appl Pharmacol       Date:  2006-11-11       Impact factor: 4.219

3.  Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling.

Authors:  Sara M Johnson; Pat Gulhati; Isela Arrieta; Xiaofu Wang; Tatsuo Uchida; Tianyan Gao; B Mark Evers
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

4.  RSF1 is a positive regulator of NF-κB-induced gene expression required for ovarian cancer chemoresistance.

Authors:  Yeong-In Yang; Ji-Hye Ahn; Kyung-Tae Lee; Ie-Ming Shih; Jung-Hye Choi
Journal:  Cancer Res       Date:  2014-02-24       Impact factor: 12.701

Review 5.  Complementary and alternative medicines in prostate cancer: from bench to bedside?

Authors:  Samuel J Klempner; Glenn Bubley
Journal:  Oncologist       Date:  2012-05-22

6.  DM-1, sodium 4-[5-(4-hydroxy-3-methoxyphenyl)-3-oxo-penta-1,4-dienyl]-2-methoxy-phenolate: a curcumin analog with a synergic effect in combination with paclitaxel in breast cancer treatment.

Authors:  Fernanda Faião-Flores; José Agustín Quincoces Suarez; Paulo Celso Pardi; Durvanei Augusto Maria
Journal:  Tumour Biol       Date:  2011-12-23

7.  Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway.

Authors:  El-Shaimaa A Arafa; Qianzheng Zhu; Bassant M Barakat; Gulzar Wani; Qun Zhao; Mohamed A El-Mahdy; Altaf A Wani
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

8.  Synergistic anti-cancer mechanisms of curcumin and paclitaxel for growth inhibition of human brain tumor stem cells and LN18 and U138MG cells.

Authors:  Motarab Hossain; Naren L Banik; Swapan K Ray
Journal:  Neurochem Int       Date:  2012-08-13       Impact factor: 3.921

Review 9.  Natural compounds with proteasome inhibitory activity for cancer prevention and treatment.

Authors:  H Yang; K R Landis-Piwowar; D Chen; V Milacic; Q P Dou
Journal:  Curr Protein Pept Sci       Date:  2008-06       Impact factor: 3.272

10.  Cell cycle inhibition and apoptosis induced by curcumin in Ewing sarcoma cell line SK-NEP-1.

Authors:  Mansher Singh; Ambarish Pandey; Collins A Karikari; Gayatri Singh; Dinesh Rakheja
Journal:  Med Oncol       Date:  2009-10-27       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.